| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |